Baxter Downgraded By Stifel On Soft Q2, Guidance Cut — But Retail Eyes A Rebound
Stifel warned that Baxter’s path to consistent growth and margin expansion may take longer than expected, pointing to a cautious 2026 outlook.
Stocktwits·1mo ago
More News
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
Baxter (BAX) delivered earnings and revenue surprises of -1.67% and -0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.
Zacks·1mo ago
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·1mo ago
Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Zacks·1mo ago
InMode (INMD) Q2 Earnings and Revenues Beat Estimates
InMode (INMD) delivered earnings and revenue surprises of +9.30% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?
BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
Zacks·1mo ago
Baxter Appoints Andrew Hider To Succeed Jose Almeida As CEO: Retail Sentiment Falters
Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), Baxter said.
Stocktwits·2mo ago
FMS Stock Likely to Gain on New Optimization Plan FME Reignite
Fresenius Medical Care unveils FME Reignite, targeting one billion euros in cost savings, tech upgrades and enhanced shareholder returns.
Zacks·3mo ago
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad